(Q35012747)

5 August 2017

1 reference

title

APOBEC deaminases-mutases with defensive roles for immunity (English)

1 reference

5 August 2017

Courtney Prochnow

1

1 reference

PubMed ID

19911124

5 August 2017

Ronda Bransteitter

series ordinal

2

1 reference

PubMed ID

19911124

5 August 2017

XiaoJiang S Chen

series ordinal

3

1 reference

5 August 2017

1 October 2009

1 reference

Science in China. Series C: Life Sciences

5 August 2017

1 reference

5 August 2017

52

1 reference

5 August 2017

893-902

1 reference

5 August 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1007/s11427-009-0133-1

5 August 2017

0 references

cites work

An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Complementary function of the two catalytic domains of APOBEC3G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Cytidine deamination of retroviral DNA by diverse APOBEC proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Constitutive expression of AID leads to tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Brca1 in immunoglobulin gene conversion and somatic hypermutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Aberrant AID expression and human cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Molecular cloning of an apolipoprotein B messenger RNA editing protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

In Vitro Deamination of Cytosine to Uracil in Single-stranded DNA by Apolipoprotein B Editing Complex Catalytic Subunit 1 (APOBEC1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

The biochemistry of somatic hypermutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

The roles of APE1, APE2, DNA polymerase beta and mismatch repair in creating S region DNA breaks during antibody class switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Immunity through DNA deamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

APOBEC3G incorporation into human immunodeficiency virus type 1 particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

The interaction of APOBEC3G with human immunodeficiency virus type 1 nucleocapsid inhibits tRNA3Lys annealing to viral RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Functional domain organization of human APOBEC3G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Target cell APOBEC3C can induce limited G-to-A mutation in HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

G to A hypermutation of hepatitis B virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

APOBEC-mediated interference with hepadnavirus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Inhibition of hepatitis B virus replication by APOBEC3G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

APOBEC3 proteins inhibit human LINE-1 retrotransposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Selective inhibition of Alu retrotransposition by APOBEC3G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

APOBEC3G: an intracellular centurion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

The APOBEC-2 crystal structure and functional implications for the deaminase AID

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Activation-induced deaminase, AID, is catalytically active as a monomer on single-stranded DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Is AID a monomer in solution?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

A model for oligomeric regulation of APOBEC3G cytosine deaminase-dependent restriction of HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Nanostructures of APOBEC3G support a hierarchical assembly model of high molecular mass ribonucleoprotein particles from dimeric subunits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

APOBEC3G subunits self-associate via the C-terminal deaminase domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

APOBEC-mediated editing of viral RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Structure, interaction and real-time monitoring of the enzymatic reaction of wild-type APOBEC3G

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

APOBEC3G DNA deaminase acts processively 3' --> 5' on single-stranded DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

DNA deamination mediates innate immunity to retroviral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

DNA deamination in immunity: AID in the context of its APOBEC relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

A portable hot spot recognition loop transfers sequence preferences from APOBEC family members to activation-induced cytidine deaminase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Mechanisms of APOBEC3G-catalyzed processive deamination of deoxycytidine on single-stranded DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Reward versus risk: DNA cytidine deaminases triggering immunity and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Regulation of activation induced deaminase via phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

Impact of phosphorylation and phosphorylation-null mutants on the activity and deamination specificity of activation-induced cytidine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-009-0133-1

10.1007/S11427-009-0133-1

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

19911124